Full-year sales reached $26.8 billion, driven by robust performance across HIV, oncology, and liver disease portfolios. HIV sales grew 8% year-over-year to $19.6 billion in 2024, exceeding ...

Businesses staying ahead in market research will be well-positioned for success in the competitive landscape of 2025 and ...